{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T21:52:15Z","timestamp":1791064335177,"version":"4.1.0"},"reference-count":171,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81820108007"],"award-info":[{"award-number":["81820108007"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","translationalres.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Translational Research"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.trsl.2026.09.005","type":"journal-article","created":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T09:52:30Z","timestamp":1789120350000},"page":"170-181","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["The role of B cell glycolysis in autoimmune diseases"],"prefix":"10.1016","volume":"297","author":[{"given":"Mengyao","family":"Shu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiman","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4451-4906","authenticated-orcid":false,"given":"Zhiguang","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingyue","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.trsl.2026.09.005_bib0001","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1038\/s41392-024-01952-8","article-title":"Evolving understanding of autoimmune mechanisms and new therapeutic strategies of autoimmune disorders","volume":"9","author":"Song","year":"2024","journal-title":"Signal Transduct Target Ther"},{"key":"10.1016\/j.trsl.2026.09.005_bib0002","doi-asserted-by":"crossref","first-page":"1878","DOI":"10.1016\/S0140-6736(23)00457-9","article-title":"Incidence, prevalence, and co-occurrence of autoimmune disorders over time and by age, sex, and socioeconomic status: a population-based cohort study of 22 million individuals in the UK","volume":"401","author":"Conrad","year":"2023","journal-title":"Lancet"},{"key":"10.1016\/j.trsl.2026.09.005_bib0003","doi-asserted-by":"crossref","DOI":"10.1016\/j.coi.2022.102266","article-title":"The increasing prevalence of autoimmunity and autoimmune diseases: an urgent call to action for improved understanding, diagnosis, treatment, and prevention","volume":"80","author":"Miller","year":"2023","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/j.trsl.2026.09.005_bib0004","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1038\/s41581-023-00720-1","article-title":"Pathogenesis of autoimmune disease","volume":"19","author":"Pisetsky","year":"2023","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/j.trsl.2026.09.005_bib0005","first-page":"1610","article-title":"Safety of immunomodulatory systemic therapies used in the management of immune-related cutaneous adverse events","volume":"16","author":"Gu","year":"2023","journal-title":"Pharm (Basel)"},{"key":"10.1016\/j.trsl.2026.09.005_bib0006","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.immuni.2021.12.012","article-title":"Metabolic adaptation of lymphocytes in immunity and disease","volume":"55","author":"Chapman","year":"2022","journal-title":"Immunity"},{"key":"10.1016\/j.trsl.2026.09.005_bib0007","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.molimm.2015.07.035","article-title":"T cell metabolism and susceptibility to autoimmune diseases","volume":"68","author":"Galgani","year":"2015","journal-title":"Mol Immunol"},{"key":"10.1016\/j.trsl.2026.09.005_bib0008","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.3389\/fimmu.2020.01027","article-title":"T cell metabolism: a new perspective on Th17\/treg cell imbalance in systemic Lupus erythematosus","volume":"11","author":"Shan","year":"2020","journal-title":"Front Immunol"},{"key":"10.1016\/j.trsl.2026.09.005_bib0009","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1080\/08923973.2024.2330645","article-title":"T-cell metabolism in rheumatoid arthritis: focus on mitochondrial and lysosomal dysfunction","volume":"46","author":"Parab","year":"2024","journal-title":"Immunopharmacol Immunotoxicol"},{"key":"10.1016\/j.trsl.2026.09.005_bib0010","article-title":"Enhanced T cell glucose uptake is associated with progression of beta-cell function in type 1 diabetes","volume":"13","author":"Tang","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.trsl.2026.09.005_bib0011","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1126\/science.1160809","article-title":"Understanding the Warburg effect: the metabolic requirements of cell proliferation","volume":"324","author":"Vander Heiden","year":"2009","journal-title":"Science"},{"key":"10.1016\/j.trsl.2026.09.005_bib0012","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1038\/nrc3038","article-title":"Otto Warburg's contributions to current concepts of cancer metabolism","volume":"11","author":"Koppenol","year":"2011","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.trsl.2026.09.005_bib0013","doi-asserted-by":"crossref","DOI":"10.1126\/science.1242454","article-title":"Fueling immunity: insights into metabolism and lymphocyte function","volume":"342","author":"Pearce","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.trsl.2026.09.005_bib0014","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2022.103116","article-title":"The role of B cell metabolism in autoimmune diseases","volume":"21","author":"Mubariki","year":"2022","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.trsl.2026.09.005_bib0015","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.cmet.2014.05.004","article-title":"The glucose transporter Glut1 is selectively essential for CD4 T cell activation and effector function","volume":"20","author":"Macintyre","year":"2014","journal-title":"Cell Metab"},{"key":"10.1016\/j.trsl.2026.09.005_bib0016","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1084\/jem.20110278","article-title":"HIF1alpha-dependent glycolytic pathway orchestrates a metabolic checkpoint for the differentiation of TH17 and treg cells","volume":"208","author":"Shi","year":"2011","journal-title":"J Exp Med"},{"key":"10.1016\/j.trsl.2026.09.005_bib0017","doi-asserted-by":"crossref","first-page":"4476","DOI":"10.4049\/jimmunol.180.7.4476","article-title":"Glucose uptake is limiting in T cell activation and requires CD28-mediated Akt-dependent and independent pathways","volume":"180","author":"Jacobs","year":"2008","journal-title":"J Immunol"},{"key":"10.1016\/j.trsl.2026.09.005_bib0018","doi-asserted-by":"crossref","first-page":"274ra218","DOI":"10.1126\/scitranslmed.aaa0835","article-title":"Normalization of CD4+ T cell metabolism reverses lupus","volume":"7","author":"Yin","year":"2015","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.trsl.2026.09.005_bib0019","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1007\/s11306-015-0772-0","article-title":"Comprehensive metabolome analyses reveal N-acetylcysteine-responsive accumulation of kynurenine in systemic lupus erythematosus: implications for activation of the mechanistic target of rapamycin","volume":"11","author":"Perl","year":"2015","journal-title":"Metabolomics"},{"key":"10.1016\/j.trsl.2026.09.005_bib0020","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/j.immuni.2013.04.005","article-title":"Metabolic pathways in immune cell activation and quiescence","volume":"38","author":"Pearce","year":"2013","journal-title":"Immunity"},{"key":"10.1016\/j.trsl.2026.09.005_bib0021","doi-asserted-by":"crossref","first-page":"80","DOI":"10.3389\/fimmu.2015.00080","article-title":"Metabolic control of B cells: more questions than answers","volume":"6","author":"Capasso","year":"2015","journal-title":"Front Immunol"},{"key":"10.1016\/j.trsl.2026.09.005_bib0022","doi-asserted-by":"crossref","first-page":"4458","DOI":"10.1182\/blood-2005-12-4788","article-title":"Antigen receptor-mediated changes in glucose metabolism in B lymphocytes: role of phosphatidylinositol 3-kinase signaling in the glycolytic control of growth","volume":"107","author":"Doughty","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.trsl.2026.09.005_bib0023","doi-asserted-by":"crossref","first-page":"3626","DOI":"10.4049\/jimmunol.1302062","article-title":"Metabolic reprogramming is required for antibody production that is suppressed in anergic but exaggerated in chronically BAFF-exposed B cells","volume":"192","author":"Caro-Maldonado","year":"2014","journal-title":"J Immunol"},{"key":"10.1016\/j.trsl.2026.09.005_bib0024","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.cmet.2017.12.007","article-title":"Let-7 suppresses B cell activation through restricting the availability of necessary nutrients","volume":"27","author":"Jiang","year":"2018","journal-title":"Cell Metab"},{"key":"10.1016\/j.trsl.2026.09.005_bib0025","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1101\/gad.17420111","article-title":"AMP-activated protein kinase: an energy sensor that regulates all aspects of cell function","volume":"25","author":"Hardie","year":"2011","journal-title":"Genes Dev"},{"key":"10.1016\/j.trsl.2026.09.005_bib0026","doi-asserted-by":"crossref","first-page":"2661","DOI":"10.4049\/jimmunol.1403088","article-title":"Metformin suppresses systemic autoimmunity in roquin(san\/san) mice through inhibiting B cell differentiation into plasma cells via regulation of AMPK\/mTOR\/STAT3","volume":"198","author":"Lee","year":"2017","journal-title":"J Immunol"},{"key":"10.1016\/j.trsl.2026.09.005_bib0027","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1038\/s41584-019-0211-0","article-title":"B cell checkpoints in autoimmune rheumatic diseases","volume":"15","author":"Rubin","year":"2019","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.trsl.2026.09.005_bib0028","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1186\/s11658-025-00749-z","article-title":"Immune cell aberrations in Systemic Lupus Erythematosus: navigating the targeted therapies toward precision management","volume":"30","author":"Wu","year":"2025","journal-title":"Cell Mol Biol Lett"},{"key":"10.1016\/j.trsl.2026.09.005_bib0029","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.biocel.2009.10.011","article-title":"The role of B cells in lupus pathogenesis","volume":"42","author":"Nashi","year":"2010","journal-title":"Int J Biochem Cell Biol"},{"key":"10.1016\/j.trsl.2026.09.005_bib0030","doi-asserted-by":"crossref","DOI":"10.3390\/ijms252010905","article-title":"Lymphocytes change their phenotype and function in systemic Lupus Erythematosus and Lupus Nephritis","volume":"25","author":"Moysidou","year":"2024","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.trsl.2026.09.005_bib0031","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1136\/ard-2022-222605","article-title":"Age-associated B cells contribute to the pathogenesis of rheumatoid arthritis by inducing activation of fibroblast-like synoviocytes via TNF-\u03b1-mediated ERK1\/2 and JAK-STAT1 pathways","volume":"81","author":"Qin","year":"2022","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.trsl.2026.09.005_bib0032","doi-asserted-by":"crossref","first-page":"7837","DOI":"10.2147\/DDDT.S527687","article-title":"Rheumatoid arthritis therapy based on B cells","volume":"Volume 19","author":"Liang","year":"2025","journal-title":"Drug Devel Ther"},{"key":"10.1016\/j.trsl.2026.09.005_bib0033","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1038\/nrneph.2017.138","article-title":"B cells in type 1 diabetes mellitus and diabetic kidney disease","volume":"13","author":"Smith","year":"2017","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/j.trsl.2026.09.005_bib0034","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1126\/science.abh1654","article-title":"Immunotherapy: building a bridge to a cure for type 1 diabetes","volume":"373","author":"Bluestone","year":"2021","journal-title":"Science"},{"key":"10.1016\/j.trsl.2026.09.005_bib0035","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/s41577-019-0154-3","article-title":"Metabolic gatekeepers to safeguard against autoimmunity and oncogenic B cell transformation","volume":"19","author":"M\u00fcschen","year":"2019","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.trsl.2026.09.005_bib0036","doi-asserted-by":"crossref","first-page":"5793","DOI":"10.3892\/mmr.2017.7367","article-title":"Association of BAFF with PI3K\/akt\/mTOR signaling in lupus nephritis","volume":"16","author":"Ge","year":"2017","journal-title":"Mol Med Rep"},{"key":"10.1016\/j.trsl.2026.09.005_bib0037","doi-asserted-by":"crossref","first-page":"425","DOI":"10.4049\/jimmunol.1601908","article-title":"Metabolic reprogramming commits differentiation of Human CD27(+)IgD(+) B cells to plasmablasts or CD27(-)IgD(-) cells","volume":"199","author":"Torigoe","year":"2017","journal-title":"J Immunol"},{"key":"10.1016\/j.trsl.2026.09.005_bib0038","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.jep.2012.02.034","article-title":"BAFF\/BAFF-R involved in antibodies production of rats with collagen-induced arthritis via PI3K-Akt-mTOR signaling and the regulation of paeoniflorin","volume":"141","author":"Li","year":"2012","journal-title":"J Ethnopharmacol"},{"key":"10.1016\/j.trsl.2026.09.005_bib0039","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1405126","article-title":"Advances in cellular and molecular pathways of salivary gland damage in Sj\u00f6gren's syndrome","volume":"15","author":"Qi","year":"2024","journal-title":"Front Immunol"},{"key":"10.1016\/j.trsl.2026.09.005_bib0040","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.smim.2012.12.004","article-title":"mTOR and metabolic pathways in T cell quiescence and functional activation","volume":"24","author":"Yang","year":"2012","journal-title":"Semin Immunol"},{"key":"10.1016\/j.trsl.2026.09.005_bib0041","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1136\/ard-2022-223035","article-title":"Global epidemiology of systemic lupus erythematosus: a comprehensive systematic analysis and modelling study","volume":"82","author":"Tian","year":"2023","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.trsl.2026.09.005_bib0042","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1038\/nrrheum.2017.43","article-title":"Immunometabolism in systemic lupus erythematosus","volume":"13","author":"Morel","year":"2017","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.trsl.2026.09.005_bib0043","doi-asserted-by":"crossref","DOI":"10.1002\/ctm2.1626","article-title":"Metabolic imbalance driving immune cell phenotype switching in autoimmune disorders: tipping the balance of T- and B-cell interactions","volume":"14","author":"Barberis","year":"2024","journal-title":"Clin Transl Med"},{"key":"10.1016\/j.trsl.2026.09.005_bib0044","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1038\/s41467-023-44540-0","article-title":"MCT1-governed pyruvate metabolism is essential for antibody class-switch recombination through H3K27 acetylation","volume":"15","author":"Chi","year":"2024","journal-title":"Nat Commun"},{"key":"10.1016\/j.trsl.2026.09.005_bib0045","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1002\/art.42433","article-title":"Amelioration of autoimmunity in a Lupus mouse model by modulation of T-bet-promoted energy metabolism in pathogenic age\/autoimmune-associated B cells","volume":"75","author":"Han","year":"2023","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.trsl.2026.09.005_bib0046","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1182\/blood-2011-01-331462","article-title":"Toll-like receptor 7 (TLR7)-driven accumulation of a novel CD11c\u207a B-cell population is important for the development of autoimmunity","volume":"118","author":"Rubtsov","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.trsl.2026.09.005_bib0047","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1241531","article-title":"Phenotypic and functional characteristics of murine CD11c+ B cells which is suppressed by metformin","volume":"14","author":"Ramirez De Oleo","year":"2023","journal-title":"Front Immunol"},{"key":"10.1016\/j.trsl.2026.09.005_bib0048","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1002\/eji.201646596","article-title":"B-cell-intrinsic function of TAPP adaptors in controlling germinal center responses and autoantibody production in mice","volume":"47","author":"Jayachandran","year":"2017","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.trsl.2026.09.005_bib0049","doi-asserted-by":"crossref","first-page":"4369","DOI":"10.1038\/s41467-018-06686-0","article-title":"Inhibition of glucose metabolism selectively targets autoreactive follicular helper T cells","volume":"9","author":"Choi","year":"2018","journal-title":"Nat Commun"},{"key":"10.1016\/j.trsl.2026.09.005_bib0050","doi-asserted-by":"crossref","first-page":"1988","DOI":"10.1093\/rheumatology\/keac528","article-title":"SLE stratification based on BAFF and IFN-I bioactivity for biologics and implications of BAFF produced by glomeruli in lupus nephritis","volume":"62","author":"Itotagawa","year":"2023","journal-title":"Rheumatol (Oxf)"},{"key":"10.1016\/j.trsl.2026.09.005_bib0051","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1084\/jem.190.11.1697","article-title":"Mice transgenic for BAFF develop lymphocytic disorders along with autoimmune manifestations","volume":"190","author":"Mackay","year":"1999","journal-title":"J Exp Med"},{"key":"10.1016\/j.trsl.2026.09.005_bib0052","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.coi.2021.05.011","article-title":"BAFF signaling in B cell metabolism","volume":"71","author":"McAllister","year":"2021","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/j.trsl.2026.09.005_bib0053","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.bcp.2013.11.006","article-title":"BAFF activates Erk1\/2 promoting cell proliferation and survival by Ca2+-CaMKII-dependent inhibition of PP2A in normal and neoplastic B-lymphoid cells","volume":"87","author":"Liang","year":"2014","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.trsl.2026.09.005_bib0054","doi-asserted-by":"crossref","first-page":"406","DOI":"10.4049\/jimmunol.1701440","article-title":"TAPP adaptors control B cell metabolism by modulating the phosphatidylinositol 3-kinase signaling pathway: a novel regulatory circuit preventing autoimmunity","volume":"201","author":"Jayachandran","year":"2018","journal-title":"J Immunol"},{"key":"10.1016\/j.trsl.2026.09.005_bib0055","doi-asserted-by":"crossref","first-page":"2186","DOI":"10.1172\/JCI30398","article-title":"Shared signaling networks active in B cells isolated from genetically distinct mouse models of lupus","volume":"117","author":"Wu","year":"2007","journal-title":"J Clin Invest"},{"key":"10.1016\/j.trsl.2026.09.005_bib0056","doi-asserted-by":"crossref","first-page":"eabn3800","DOI":"10.1126\/sciimmunol.abn3800","article-title":"Immunodeficiency, autoimmunity, and increased risk of B cell malignancy in humans with TRAF3 mutations","volume":"7","author":"Rae","year":"2022","journal-title":"Sci Immunol"},{"key":"10.1016\/j.trsl.2026.09.005_bib0057","doi-asserted-by":"crossref","DOI":"10.1038\/srep35349","article-title":"TRAF3 deficiency promotes metabolic reprogramming in B cells","volume":"6","author":"Mambetsariev","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.trsl.2026.09.005_bib0058","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.immuni.2007.07.012","article-title":"Tumor necrosis factor receptor-associated factor 3 is a critical regulator of B cell homeostasis in secondary lymphoid organs","volume":"27","author":"Xie","year":"2007","journal-title":"Immunity"},{"key":"10.1016\/j.trsl.2026.09.005_bib0059","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.1016\/S0140-6736(16)30173-8","article-title":"Rheumatoid arthritis","volume":"388","author":"Smolen","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.trsl.2026.09.005_bib0060","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1038\/nrrheum.2018.10","article-title":"The B cell response to citrullinated antigens in the development of rheumatoid arthritis","volume":"14","author":"Scherer","year":"2018","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.trsl.2026.09.005_bib0061","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2023.110532","article-title":"IL-27 enhances peripheral B cell glycolysis of rheumatoid arthritis patients via activating mTOR signaling","volume":"121","author":"Qi","year":"2023","journal-title":"Int Immunopharmacol"},{"key":"10.1016\/j.trsl.2026.09.005_bib0062","doi-asserted-by":"crossref","first-page":"1973","DOI":"10.3389\/fimmu.2018.01973","article-title":"Inhibition of glycolysis reduces disease severity in an autoimmune model of rheumatoid arthritis","volume":"9","author":"Abboud","year":"2018","journal-title":"Front Immunol"},{"key":"10.1016\/j.trsl.2026.09.005_bib0063","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1038\/s41584-022-00786-4","article-title":"From risk to chronicity: evolution of autoreactive B cell and antibody responses in rheumatoid arthritis","volume":"18","author":"Scherer","year":"2022","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.trsl.2026.09.005_bib0064","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1111\/j.1756-185X.2011.01598.x","article-title":"Glycolysis and rheumatoid arthritis","volume":"14","author":"Chang","year":"2011","journal-title":"Int J Rheum Dis"},{"key":"10.1016\/j.trsl.2026.09.005_bib0065","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1453587","article-title":"The role of lactylation in plasma cells and its impact on rheumatoid arthritis pathogenesis: insights from single-cell RNA sequencing and machine learning","volume":"15","author":"Fu","year":"2024","journal-title":"Front Immunol"},{"key":"10.1016\/j.trsl.2026.09.005_bib0066","doi-asserted-by":"crossref","DOI":"10.1172\/JCI150274","article-title":"Plasma cells promote osteoclastogenesis and periarticular bone loss in autoimmune arthritis","volume":"131","author":"Komatsu","year":"2021","journal-title":"J Clin Invest"},{"key":"10.1016\/j.trsl.2026.09.005_bib0067","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1111\/imm.13598","article-title":"Characterization of age-associated B cells in early drug-na\u00efve rheumatoid arthritis patients","volume":"168","author":"Vidal-Pedrola","year":"2023","journal-title":"Immunology"},{"key":"10.1016\/j.trsl.2026.09.005_bib0068","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellimm.2022.104533","article-title":"Age-associated B cells indicate disease activity in rheumatoid arthritis","volume":"377","author":"Bao","year":"2022","journal-title":"Cell Immunol"},{"key":"10.1016\/j.trsl.2026.09.005_bib0069","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1007\/s12016-025-09021-w","article-title":"Age-associated B cells in autoimmune diseases: pathogenesis and clinical implications","volume":"68","author":"Xie","year":"2025","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1016\/j.trsl.2026.09.005_bib0070","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1007\/s00011-016-0965-7","article-title":"PGK1, a glucose metabolism enzyme, may play an important role in rheumatoid arthritis","volume":"65","author":"Zhao","year":"2016","journal-title":"Inflamm Res"},{"key":"10.1016\/j.trsl.2026.09.005_bib0071","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/s12016-020-08821-6","article-title":"Immunometabolic pathways and its therapeutic implication in autoimmune diseases","volume":"60","author":"Wang","year":"2021","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1016\/j.trsl.2026.09.005_bib0072","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1038\/s41401-020-00582-4","article-title":"BAFF, involved in B cell activation through the NF-\u03baB pathway, is related to disease activity and bone destruction in rheumatoid arthritis","volume":"42","author":"Zhang","year":"2021","journal-title":"Acta Pharmacol Sin"},{"key":"10.1016\/j.trsl.2026.09.005_bib0073","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.139032","article-title":"Pathogenic, glycolytic PD-1+ B cells accumulate in the hypoxic RA joint","volume":"5","author":"Floudas","year":"2020","journal-title":"JCI Insight"},{"key":"10.1016\/j.trsl.2026.09.005_bib0074","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1038\/s41573-019-0032-5","article-title":"Targeting metabolism to regulate immune responses in autoimmunity and cancer","volume":"18","author":"Patel","year":"2019","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.trsl.2026.09.005_bib0075","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2024.111913","article-title":"Glycolysis, a driving force of rheumatoid arthritis","volume":"132","author":"Gan","year":"2024","journal-title":"Int Immunopharmacol"},{"key":"10.1016\/j.trsl.2026.09.005_bib0076","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1038\/s41574-025-01128-6","article-title":"Type 1 diabetes mellitus prevention: present and future","volume":"21","author":"Henriques","year":"2025","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/j.trsl.2026.09.005_bib0077","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2025.105593","article-title":"TCL1A in na\u00efve B cells as a therapeutic target for type 1 diabetes","volume":"113","author":"Luo","year":"2025","journal-title":"EBioMedicine"},{"key":"10.1016\/j.trsl.2026.09.005_bib0078","article-title":"Gut microbiota from B-cell-specific TLR9-deficient NOD mice promote IL-10(+) breg cells and protect against T1D","volume":"15","author":"Yang","year":"2024","journal-title":"Front Immunol"},{"key":"10.1016\/j.trsl.2026.09.005_bib0079","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a041593","article-title":"The role of B lymphocytes in type 1 diabetes","volume":"15","author":"Smith","year":"2025","journal-title":"Cold Spring Harb Perspect Med"},{"key":"10.1016\/j.trsl.2026.09.005_bib0080","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.2337\/db15-1615","article-title":"Differential insulitic profiles determine the extent of \u03b2-cell destruction and the age at onset of type 1 diabetes","volume":"65","author":"Leete","year":"2016","journal-title":"Diabetes"},{"key":"10.1016\/j.trsl.2026.09.005_bib0081","doi-asserted-by":"crossref","first-page":"2449","DOI":"10.1016\/S0140-6736(18)31320-5","article-title":"Type 1 diabetes","volume":"391","author":"DiMeglio","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.trsl.2026.09.005_bib0082","doi-asserted-by":"crossref","first-page":"3857","DOI":"10.1172\/JCI32405","article-title":"Treatment with CD20-specific antibody prevents and reverses autoimmune diabetes in mice","volume":"117","author":"Hu","year":"2007","journal-title":"J Clin Invest"},{"key":"10.1016\/j.trsl.2026.09.005_bib0083","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1093\/intimm\/9.8.1159","article-title":"Direct evidence for the contribution of B cells to the progression of insulitis and the development of diabetes in non-obese diabetic mice","volume":"9","author":"Akashi","year":"1997","journal-title":"Int Immunol"},{"key":"10.1016\/j.trsl.2026.09.005_bib0084","doi-asserted-by":"crossref","first-page":"2143","DOI":"10.1056\/NEJMoa0904452","article-title":"Rituximab, B-lymphocyte depletion, and preservation of beta-cell function","volume":"361","author":"Pescovitz","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.trsl.2026.09.005_bib0085","doi-asserted-by":"crossref","DOI":"10.1016\/j.clim.2023.109729","article-title":"Elevated glucose metabolism driving pro-inflammatory response in B cells contributes to the progression of type 1 diabetes","volume":"255","author":"Li","year":"2023","journal-title":"Clin Immunol"},{"key":"10.1016\/j.trsl.2026.09.005_bib0086","doi-asserted-by":"crossref","DOI":"10.1093\/jimmun\/vkaf330","article-title":"Altered B cell metabolic pathways characterize type 1 diabetes progression","volume":"215","author":"Conway","year":"2026","journal-title":"J Immunol"},{"key":"10.1016\/j.trsl.2026.09.005_bib0087","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1016\/j.ymthe.2025.12.003","article-title":"Innate immune cell-derived BAFF induces non-canonical NF-\u03bab activation to promote inflammatory response of ICOSL(+) B cells in diabetic autoimmunity","volume":"34","author":"Li","year":"2026","journal-title":"Mol Ther"},{"key":"10.1016\/j.trsl.2026.09.005_bib0088","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2025.105946","article-title":"Monocyte\/macrophage-derived interleukin-15 mediates the pro-inflammatory phenotype of CD226(+) B cells in type 1 diabetes","volume":"120","author":"Li","year":"2025","journal-title":"EBioMedicine"},{"key":"10.1016\/j.trsl.2026.09.005_bib0089","doi-asserted-by":"crossref","first-page":"6943","DOI":"10.1111\/dom.70092","article-title":"The protective role of TIGIT+ B cells in attenuating type 1 diabetes progression","volume":"27","author":"Peng","year":"2025","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.trsl.2026.09.005_bib0090","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1111\/1756-185X.12583","article-title":"Clinical and laboratory profiles of primary Sjogren's syndrome in a Chinese population: a retrospective analysis of 315 patients","volume":"18","author":"Li","year":"2015","journal-title":"Int J Rheum Dis"},{"key":"10.1016\/j.trsl.2026.09.005_bib0091","first-page":"247","article-title":"The epidemiology of Sj\u00f6gren's syndrome","volume":"6","author":"Patel","year":"2014","journal-title":"Clin Epidemiol"},{"key":"10.1016\/j.trsl.2026.09.005_bib0092","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2025.103852","article-title":"The role of B cells in Sj\u00f6gren's syndrome and their impact on the nervous system","volume":"24","author":"Su","year":"2025","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.trsl.2026.09.005_bib0093","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1111\/imm.13580","article-title":"mTORC1-GLUT1-mediated glucose metabolism drives hyperactivation of B cells in primary Sjogren's syndrome","volume":"168","author":"Luo","year":"2023","journal-title":"Immunology"},{"key":"10.1016\/j.trsl.2026.09.005_bib0094","article-title":"Analysis of TNFSF13B polymorphisms and BAFF expression in rheumatoid arthritis and primary Sj\u00f6gren's syndrome patients","volume":"10","author":"Santill\u00e1n-L\u00f3pez","year":"2022","journal-title":"Mol Genet Genom Med"},{"key":"10.1016\/j.trsl.2026.09.005_bib0095","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1038\/s41584-024-01167-9","article-title":"Epstein-Barr virus as a potentiator of autoimmune diseases","volume":"20","author":"Robinson","year":"2024","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.trsl.2026.09.005_bib0096","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1080\/1040841X.2024.2344114","article-title":"The role of Epstein-Barr virus in autoimmune and autoinflammatory diseases","volume":"51","author":"Borghol","year":"2025","journal-title":"Crit Rev Microbiol"},{"key":"10.1016\/j.trsl.2026.09.005_bib0097","doi-asserted-by":"crossref","first-page":"3944","DOI":"10.3390\/ijms25073944","article-title":"Epstein-Barr Virus latent membrane protein 2A (LMP2A) enhances ATP production in B cell tumors through mTOR and HIF-1\u03b1","volume":"25","author":"Incrocci","year":"2024","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.trsl.2026.09.005_bib0098","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1186\/s12885-024-13013-y","article-title":"A narrative review: exploring viral-induced malignancies through the lens of dysregulated cellular metabolism and glucose transporters","volume":"24","author":"Shahpar","year":"2024","journal-title":"BMC Cancer"},{"key":"10.1016\/j.trsl.2026.09.005_bib0099","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.it.2024.11.011","article-title":"Epstein-Barr virus hijacks B cell metabolism to establish persistent infection and drive pathogenesis","volume":"46","author":"M\u00fcller-Durovic","year":"2025","journal-title":"Trends Immunol"},{"key":"10.1016\/j.trsl.2026.09.005_bib0100","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1080\/1744666X.2021.1901582","article-title":"Germline IKZF1 mutations and their impact on immunity: IKAROS-associated diseases and pathophysiology","volume":"17","author":"Kuehn","year":"2021","journal-title":"Expert Rev Clin Immunol"},{"key":"10.1016\/j.trsl.2026.09.005_bib0101","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.jaci.2016.09.029","article-title":"Abnormal hematopoiesis and autoimmunity in human subjects with germline IKZF1 mutations","volume":"140","author":"Hoshino","year":"2017","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.trsl.2026.09.005_bib0102","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/j.jaci.2018.04.008","article-title":"A kindred with mutant IKAROS and autoimmunity","volume":"142","author":"Van Nieuwenhove","year":"2018","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.trsl.2026.09.005_bib0103","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/j.jaci.2024.03.018","article-title":"IgG4-related disease and B-cell malignancy due to an IKZF1 gain-of-function variant","volume":"154","author":"Garc\u00eda-Sol\u00eds","year":"2024","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.trsl.2026.09.005_bib0104","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1002\/art.70017","article-title":"Single-cell RNA sequencing informs precision targeting of monogenic lupus associated with IKZF1 haploinsufficiency","volume":"78","author":"Zheng","year":"2026","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.trsl.2026.09.005_bib0105","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1002\/eji.200637026","article-title":"Expression of a non-DNA-binding Ikaros isoform exclusively in B cells leads to autoimmunity but not leukemogenesis","volume":"37","author":"Wojcik","year":"2007","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.trsl.2026.09.005_bib0106","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1038\/nature21076","article-title":"Metabolic gatekeeper function of B-lymphoid transcription factors","volume":"542","author":"Chan","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.trsl.2026.09.005_bib0107","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2025.110684","article-title":"Adductome-based identification of lysine monomethylation as a key post-translational protein modification in autoimmune diseases","volume":"301","author":"Yamaguchi","year":"2025","journal-title":"J Biol Chem"},{"key":"10.1016\/j.trsl.2026.09.005_bib0108","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1002\/art.41083","article-title":"Population-specific patterns of epigenetic defects in the B cell lineage in patients with systemic Lupus Erythematosus","volume":"72","author":"Breitbach","year":"2020","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.trsl.2026.09.005_bib0109","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/1471-2377-5-19","article-title":"Early B-cell Factor gene association with multiple sclerosis in the Spanish population","volume":"5","author":"Mart\u00ednez","year":"2005","journal-title":"BMC Neurol"},{"key":"10.1016\/j.trsl.2026.09.005_bib0110","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1053\/j.gastro.2012.01.011","article-title":"Autoimmunity, intestinal lymphoid hyperplasia, and defects in mucosal B-cell homeostasis in patients with PTEN hamartoma tumor syndrome","volume":"142","author":"Heindl","year":"2012","journal-title":"Gastroenterology"},{"key":"10.1016\/j.trsl.2026.09.005_bib0111","doi-asserted-by":"crossref","first-page":"3635","DOI":"10.1172\/JCI45790","article-title":"The PTPN22 allele encoding an R620W variant interferes with the removal of developing autoreactive B cells in humans","volume":"121","author":"Menard","year":"2011","journal-title":"J Clin Invest"},{"key":"10.1016\/j.trsl.2026.09.005_bib0112","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.aaf7153","article-title":"PTPN22 inhibition resets defective human central B cell tolerance","volume":"1","author":"Schickel","year":"2016","journal-title":"Sci Immunol"},{"key":"10.1016\/j.trsl.2026.09.005_bib0113","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/s10875-025-01938-3","article-title":"Homozygous loss of function PIK3CD mutation in multiple siblings leading to B cell dysregulation and autoimmunity","volume":"45","author":"Alajlan","year":"2025","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.trsl.2026.09.005_bib0114","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20191336","article-title":"Activated PI3K\u03b4 breaches multiple B cell tolerance checkpoints and causes autoantibody production","volume":"217","author":"Lau","year":"2020","journal-title":"J Exp Med"},{"key":"10.1016\/j.trsl.2026.09.005_bib0115","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s10875-024-01793-8","article-title":"Biallelic PI4KA mutations disrupt B-cell metabolism and cause B-cell lymphopenia and hypogammaglobulinemia","volume":"45","author":"Saettini","year":"2025","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.trsl.2026.09.005_bib0116","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.immuni.2007.04.016","article-title":"B cell-specific deletion of protein-tyrosine phosphatase Shp1 promotes B-1a cell development and causes systemic autoimmunity","volume":"27","author":"Pao","year":"2007","journal-title":"Immunity"},{"key":"10.1016\/j.trsl.2026.09.005_bib0117","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2023.107487","article-title":"Glucose oxidation-dependent survival of activated B cells provides a putative novel therapeutic target for lupus treatment","volume":"26","author":"Wilson","year":"2023","journal-title":"iScience"},{"key":"10.1016\/j.trsl.2026.09.005_bib0118","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1038\/ni.3664","article-title":"Gsk3 is a metabolic checkpoint regulator in B cells","volume":"18","author":"Jellusova","year":"2017","journal-title":"Nat Immunol"},{"key":"10.1016\/j.trsl.2026.09.005_bib0119","doi-asserted-by":"crossref","first-page":"377","DOI":"10.4049\/jimmunol.2200325","article-title":"Glucose requirement of antigen-specific autoreactive B cells and CD4+ T cells","volume":"210","author":"Abboud","year":"2023","journal-title":"J Immunol"},{"key":"10.1016\/j.trsl.2026.09.005_bib0120","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1136\/annrheumdis-2019-215039","article-title":"Lupus-associated atypical memory B cells are mTORC1-hyperactivated and functionally dysregulated","volume":"78","author":"Wu","year":"2019","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.trsl.2026.09.005_bib0121","doi-asserted-by":"crossref","first-page":"833","DOI":"10.3389\/fimmu.2019.00833","article-title":"Targeting T cell activation and Lupus autoimmune phenotypes by inhibiting glucose transporters","volume":"10","author":"Li","year":"2019","journal-title":"Front Immunol"},{"key":"10.1016\/j.trsl.2026.09.005_bib0122","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/S0140-6736(10)61354-2","article-title":"Efficacy and safety of belimumab in patients with active systemic lupus erythematosus: a randomised, placebo-controlled, phase 3 trial","volume":"377","author":"Navarra","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.trsl.2026.09.005_bib0123","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1002\/art.42462","article-title":"Povetacicept, an enhanced dual APRIL\/BAFF antagonist that modulates B lymphocytes and pathogenic autoantibodies for the treatment of Lupus and other B cell-related autoimmune diseases","volume":"75","author":"Evans","year":"2023","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.trsl.2026.09.005_bib0124","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1111\/imr.12847","article-title":"Metabolic determinants of lupus pathogenesis","volume":"295","author":"Teng","year":"2020","journal-title":"Immunol Rev"},{"key":"10.1016\/j.trsl.2026.09.005_bib0125","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2021.107771","article-title":"Metformin prevents BAFF activation of Erk1\/2 from B-cell proliferation and survival by impeding mTOR-PTEN\/Akt signaling pathway","volume":"96","author":"Chen","year":"2021","journal-title":"Int Immunopharmacol"},{"key":"10.1016\/j.trsl.2026.09.005_bib0126","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1038\/s41422-020-0291-z","article-title":"Targeting immunometabolism as an anti-inflammatory strategy","volume":"30","author":"P\u00e5lsson-McDermott","year":"2020","journal-title":"Cell Res"},{"key":"10.1016\/j.trsl.2026.09.005_bib0127","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abb6296","article-title":"B cells polarize pathogenic inflammatory T helper subsets through ICOSL-dependent glycolysis","volume":"6","author":"Zeng","year":"2020","journal-title":"Sci Adv"},{"key":"10.1016\/j.trsl.2026.09.005_bib0128","doi-asserted-by":"crossref","first-page":"e355","DOI":"10.1016\/S2665-9913(24)00338-2","article-title":"Evolution and trajectory of B-cell targeted therapies in rheumatic diseases","volume":"7","author":"Carter","year":"2025","journal-title":"Lancet Rheumatol"},{"key":"10.1016\/j.trsl.2026.09.005_bib0129","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1007\/s00011-020-01332-2","article-title":"Inhibition of glycolysis ameliorate arthritis in adjuvant arthritis rats by inhibiting synoviocyte activation through AMPK\/NF-\u043aB pathway","volume":"69","author":"Wang","year":"2020","journal-title":"Inflamm Res"},{"key":"10.1016\/j.trsl.2026.09.005_bib0130","doi-asserted-by":"crossref","first-page":"R132","DOI":"10.1186\/ar2799","article-title":"Dichloroacetate alleviates development of collagen II-induced arthritis in female DBA\/1 mice","volume":"11","author":"Bian","year":"2009","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.trsl.2026.09.005_bib0131","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.757616","article-title":"Iguratimod restrains circulating follicular helper T cell function by inhibiting glucose metabolism via Hif1\u03b1-HK2 axis in rheumatoid arthritis","volume":"13","author":"Bai","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.trsl.2026.09.005_bib0132","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1172\/JCI13505","article-title":"Role of AMP-activated protein kinase in mechanism of metformin action","volume":"108","author":"Zhou","year":"2001","journal-title":"J Clin Invest"},{"key":"10.1016\/j.trsl.2026.09.005_bib0133","doi-asserted-by":"crossref","first-page":"e507","DOI":"10.1210\/clinem\/dgaa791","article-title":"Rapamycin plus Vildagliptin to recover \u03b2-cell function in long-standing type 1 diabetes: a double-blind, randomized trial","volume":"106","author":"Bolla","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.trsl.2026.09.005_bib0134","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1038\/s41392-025-02415-4","article-title":"Multiple sclerosis: molecular pathogenesis and therapeutic intervention","volume":"10","author":"Boutitah-Benyaich","year":"2025","journal-title":"Signal Transduct Target Ther"},{"key":"10.1016\/j.trsl.2026.09.005_bib0135","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1056\/NEJMcibr2032177","article-title":"Antigen presentation by B cells in multiple sclerosis","volume":"384","author":"Zamvil","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.trsl.2026.09.005_bib0136","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1056\/NEJMoa1601277","article-title":"Ocrelizumab versus interferon beta-1a in relapsing multiple sclerosis","volume":"376","author":"Hauser","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.trsl.2026.09.005_bib0137","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1056\/NEJMoa1917246","article-title":"Ofatumumab versus Teriflunomide in Multiple sclerosis","volume":"383","author":"Hauser","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.trsl.2026.09.005_bib0138","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1007\/s00401-022-02411-w","article-title":"BTK inhibition limits B-cell-T-cell interaction through modulation of B-cell metabolism: implications for multiple sclerosis therapy","volume":"143","author":"Li","year":"2022","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.trsl.2026.09.005_bib0139","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1172\/JCI76012","article-title":"Metabolic programming and PDHK1 control CD4+ T cell subsets and inflammation","volume":"125","author":"Gerriets","year":"2015","journal-title":"J Clin Invest"},{"key":"10.1016\/j.trsl.2026.09.005_bib0140","doi-asserted-by":"crossref","first-page":"14026","DOI":"10.1111\/jcmm.16013","article-title":"Metabolic reprogramming of glycolysis and glutamine metabolism are key events in myofibroblast transition in systemic sclerosis pathogenesis","volume":"24","author":"Henderson","year":"2020","journal-title":"J Cell Mol Med"},{"key":"10.1016\/j.trsl.2026.09.005_bib0141","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.163030","article-title":"A randomized, phase II study of sequential belimumab and rituximab in primary Sj\u00f6gren's syndrome","volume":"7","author":"Mariette","year":"2022","journal-title":"JCI Insight"},{"key":"10.1016\/j.trsl.2026.09.005_bib0142","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1136\/annrheumdis-2018-214720","article-title":"Treatment of primary Sj\u00f6gren's syndrome with ianalumab (VAY736) targeting B cells by BAFF receptor blockade coupled with enhanced, antibody-dependent cellular cytotoxicity","volume":"78","author":"D\u00f6rner","year":"2019","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.trsl.2026.09.005_bib0143","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.bbrc.2021.11.102","article-title":"A novel PDK1 inhibitor, JX06, inhibits glycolysis and induces apoptosis in multiple myeloma cells","volume":"587","author":"Kawano","year":"2022","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.trsl.2026.09.005_bib0144","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1038\/bjc.2012.527","article-title":"PDK1 inhibition is a novel therapeutic target in multiple myeloma","volume":"108","author":"Fujiwara","year":"2013","journal-title":"Br J Cancer"},{"key":"10.1016\/j.trsl.2026.09.005_bib0145","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1038\/nri3804","article-title":"Dynamics of B cells in germinal centres","volume":"15","author":"De Silva","year":"2015","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.trsl.2026.09.005_bib0146","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1038\/nature19334","article-title":"Germinal centre hypoxia and regulation of antibody qualities by a hypoxia response system","volume":"537","author":"Cho","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.trsl.2026.09.005_bib0147","doi-asserted-by":"crossref","first-page":"4014","DOI":"10.4049\/jimmunol.1601401","article-title":"Germinal center hypoxia potentiates immunoglobulin class switch recombination","volume":"197","author":"Abbott","year":"2016","journal-title":"J Immunol"},{"key":"10.1016\/j.trsl.2026.09.005_bib0148","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2024.113739","article-title":"GLUT1-mediated glucose import in B cells is critical for anaplerotic balance and humoral immunity","volume":"43","author":"Bierling","year":"2024","journal-title":"Cell Rep"},{"key":"10.1016\/j.trsl.2026.09.005_bib0149","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1038\/s41590-023-01540-y","article-title":"Distinct metabolic requirements regulate B cell activation and germinal center responses","volume":"24","author":"Sharma","year":"2023","journal-title":"Nat Immunol"},{"key":"10.1016\/j.trsl.2026.09.005_bib0150","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1038\/s41590-020-0598-4","article-title":"Germinal center B cells selectively oxidize fatty acids for energy while conducting minimal glycolysis","volume":"21","author":"Weisel","year":"2020","journal-title":"Nat Immunol"},{"key":"10.1016\/j.trsl.2026.09.005_bib0151","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2024.103326","article-title":"Regulatory B cells in autoimmune diseases: insights and therapeutic potential","volume":"149","author":"Su","year":"2024","journal-title":"J Autoimmun"},{"key":"10.1016\/j.trsl.2026.09.005_bib0152","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1016\/j.ekir.2020.04.019","article-title":"Regulatory B and T cells and their association with clinical response in new-onset lupus nephritis patients","volume":"5","author":"Girimaji","year":"2020","journal-title":"Kidney Int Rep"},{"key":"10.1016\/j.trsl.2026.09.005_bib0153","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/s13075-016-1213-9","article-title":"TIM-1 defines a human regulatory B cell population that is altered in frequency and function in systemic sclerosis patients","volume":"19","author":"Aravena","year":"2017","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.trsl.2026.09.005_bib0154","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.588500","article-title":"Granulocytic myeloid-derived suppressor cell exosomal prostaglandin E2 ameliorates collagen-induced arthritis by enhancing IL-10(+) B cells","volume":"11","author":"Wu","year":"2020","journal-title":"Front Immunol"},{"key":"10.1016\/j.trsl.2026.09.005_bib0155","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1111\/cei.12639","article-title":"Remission of systemic lupus erythematosus disease activity with regulatory cytokine interleukin (IL)-35 in Murphy Roths large (MRL)\/lpr mice","volume":"181","author":"Cai","year":"2015","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.trsl.2026.09.005_bib0156","doi-asserted-by":"crossref","first-page":"2403","DOI":"10.1007\/s10067-022-06137-8","article-title":"Interleukin-35 promotes breg expansion and interleukin-10 production in CD19(+) B cells in patients with ankylosing spondylitis","volume":"41","author":"Zhang","year":"2022","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.trsl.2026.09.005_bib0157","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1016\/j.cmet.2021.05.008","article-title":"The emerging field of regulatory B cell immunometabolism","volume":"33","author":"Rosser","year":"2021","journal-title":"Cell Metab"},{"key":"10.1016\/j.trsl.2026.09.005_bib0158","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1038\/s41467-017-02683-x","article-title":"Hypoxia-inducible factor-1\u03b1 is a critical transcription factor for IL-10-producing B cells in autoimmune disease","volume":"9","author":"Meng","year":"2018","journal-title":"Nat Commun"},{"key":"10.1016\/j.trsl.2026.09.005_bib0159","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1038\/s41392-022-00948-6","article-title":"c-myc-driven glycolysis polarizes functional regulatory B cells that trigger pathogenic inflammatory responses","volume":"7","author":"Wang","year":"2022","journal-title":"Signal Transduct Target Ther"},{"key":"10.1016\/j.trsl.2026.09.005_bib0160","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1038\/s41590-024-01798-w","article-title":"Thioredoxin is a metabolic rheostat controlling regulatory B cells","volume":"25","author":"Bradford","year":"2024","journal-title":"Nat Immunol"},{"key":"10.1016\/j.trsl.2026.09.005_bib0161","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.isci.2018.07.005","article-title":"Initial B cell activation induces metabolic reprogramming and mitochondrial remodeling","volume":"5","author":"Waters","year":"2018","journal-title":"iScience"},{"key":"10.1016\/j.trsl.2026.09.005_bib0162","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1038\/s41590-019-0490-2","article-title":"Ikaros prevents autoimmunity by controlling anergy and toll-like receptor signaling in B cells","volume":"20","author":"Schwickert","year":"2019","journal-title":"Nat Immunol"},{"key":"10.1016\/j.trsl.2026.09.005_bib0163","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/j.immuni.2009.08.026","article-title":"Suppression of phosphatidylinositol 3,4,5-trisphosphate production is a key determinant of B cell anergy","volume":"31","author":"Browne","year":"2009","journal-title":"Immunity"},{"key":"10.1016\/j.trsl.2026.09.005_bib0164","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/s41577-019-0154-3","article-title":"Metabolic gatekeepers to safeguard against autoimmunity and oncogenic B cell transformation","volume":"19","author":"Muschen","year":"2019","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.trsl.2026.09.005_bib0165","doi-asserted-by":"crossref","first-page":"L300","DOI":"10.1152\/ajplung.00221.2011","article-title":"The role of low-level lactate production in airway inflammation in asthma","volume":"302","author":"Ostroukhova","year":"2012","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"10.1016\/j.trsl.2026.09.005_bib0166","doi-asserted-by":"crossref","first-page":"9288","DOI":"10.1073\/pnas.1805717115","article-title":"Pyruvate dehydrogenase phosphatase catalytic subunit 2 limits Th17 differentiation","volume":"115","author":"Kono","year":"2018","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.trsl.2026.09.005_bib0167","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2024.122760","article-title":"Inflammatory stimulus-responsive polymersomes reprogramming glucose metabolism mitigates rheumatoid arthritis","volume":"312","author":"Wang","year":"2025","journal-title":"Biomaterials"},{"key":"10.1016\/j.trsl.2026.09.005_bib0168","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.911730","article-title":"Efficacy and safety of belimumab\/low-dose cyclophosphamide therapy in moderate-to-severe systemic lupus erythematosus","volume":"13","author":"Cheng","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.trsl.2026.09.005_bib0169","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1007\/s00125-018-4638-7","article-title":"A selective CD28 antagonist and rapamycin synergise to protect against spontaneous autoimmune diabetes in NOD mice","volume":"61","author":"Besan\u00e7on","year":"2018","journal-title":"Diabetologia"},{"key":"10.1016\/j.trsl.2026.09.005_bib0170","doi-asserted-by":"crossref","first-page":"638","DOI":"10.2337\/diabetes.51.3.638","article-title":"Combination therapy with sirolimus and interleukin-2 prevents spontaneous and recurrent autoimmune diabetes in NOD mice","volume":"51","author":"Rabinovitch","year":"2002","journal-title":"Diabetes"},{"key":"10.1016\/j.trsl.2026.09.005_bib0171","doi-asserted-by":"crossref","first-page":"2098","DOI":"10.4049\/jimmunol.2100356","article-title":"Pharmacologically inferred glycolysis and glutaminolysis requirement of B cells in lupus-prone mice","volume":"208","author":"Choi","year":"2022","journal-title":"J Immunol"}],"container-title":["Translational Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1931524426001908?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1931524426001908?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T20:53:55Z","timestamp":1791060835000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1931524426001908"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":171,"alternative-id":["S1931524426001908"],"URL":"https:\/\/doi.org\/10.1016\/j.trsl.2026.09.005","relation":{},"ISSN":["1931-5244"],"issn-type":[{"value":"1931-5244","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The role of B cell glycolysis in autoimmune diseases","name":"articletitle","label":"Article Title"},{"value":"Translational Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.trsl.2026.09.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}